KR890002547A - Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 - Google Patents

Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드

Info

Publication number
KR890002547A
KR890002547A KR1019870009058A KR870009058A KR890002547A KR 890002547 A KR890002547 A KR 890002547A KR 1019870009058 A KR1019870009058 A KR 1019870009058A KR 870009058 A KR870009058 A KR 870009058A KR 890002547 A KR890002547 A KR 890002547A
Authority
KR
South Korea
Prior art keywords
peptides
diagnosis
treatment
monoclonal antibodies
hiv infection
Prior art date
Application number
KR1019870009058A
Other languages
English (en)
Other versions
KR920008744B1 (ko
Inventor
캐틀린 스리버 매리
케이. 토머스 엘레인
엘. 코산드 웨슬리
에이치. 고스팅 라리
에스 딕킨슨 에드나
먹클루어 제넬라(엔엠아이)
제이. 토라도 조지
씨. 노윈스키 로버트
Original Assignee
제네틱 시스팀스 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제네틱 시스팀스 코포레이션 filed Critical 제네틱 시스팀스 코포레이션
Publication of KR890002547A publication Critical patent/KR890002547A/ko
Application granted granted Critical
Publication of KR920008744B1 publication Critical patent/KR920008744B1/ko

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019870009058A 1986-08-20 1987-08-19 Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 KR920008744B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US45026 1987-05-01
US6799687A 1987-06-29 1987-06-29
US67996 1987-06-29
US898273 1992-06-15

Publications (2)

Publication Number Publication Date
KR890002547A true KR890002547A (ko) 1989-04-10
KR920008744B1 KR920008744B1 (ko) 1992-10-09

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870009058A KR920008744B1 (ko) 1986-08-20 1987-08-19 Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드

Country Status (28)

Country Link
JP (1) JPS6485928A (ko)
KR (1) KR920008744B1 (ko)
AT (1) AT398080B (ko)
AU (1) AU616156B2 (ko)
BE (1) BE1000811A4 (ko)
CH (1) CH675728A5 (ko)
CS (1) CS275838B6 (ko)
DE (1) DE3727703A1 (ko)
DK (1) DK433087A (ko)
ES (1) ES2010727A6 (ko)
FI (1) FI873553A (ko)
FR (1) FR2603107B1 (ko)
GB (1) GB2196634B (ko)
GR (1) GR871298B (ko)
HU (1) HU214439B (ko)
IE (1) IE60671B1 (ko)
IL (1) IL83580A (ko)
IT (1) IT1222518B (ko)
LU (1) LU86972A1 (ko)
NL (1) NL8701950A (ko)
NO (2) NO300462B1 (ko)
NZ (1) NZ221440A (ko)
OA (1) OA08652A (ko)
PL (1) PL155084B1 (ko)
PT (1) PT85567B (ko)
SE (1) SE506025C2 (ko)
YU (1) YU152587A (ko)
ZW (1) ZW15487A1 (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
DE68926499T2 (de) * 1988-01-26 1996-12-19 The United States Of America, Represented By The Secretary, U.S. Department Of Commerce, Springfield, Va. Synthetisches antigen zum bewirken einer anti-hiv-reaktion
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
EP0436634A1 (en) * 1988-10-03 1991-07-17 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
WO1993020102A1 (en) * 1992-03-27 1993-10-14 Peptide Technology Limited Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
BRPI0620566B8 (pt) 2005-12-09 2021-05-25 Vectus Biosystems Ltd composição, composição para o tratamento profilático ou terapêutico de fibrose miocardial ou uma condição associada, composição para o tratamento profilático ou terapêutico de hipertensão, uso de uma composição, uso de vip ou de um fragmento do mesmo e uso de um vip
WO2010026940A1 (ja) 2008-09-02 2010-03-11 日本特殊陶業株式会社 スパークプラグ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE3587181T2 (de) * 1984-10-18 1993-06-24 Centre Nat Rech Scient F antigene vom menschlichen immunodefizienz-virus und deren verwendungen.
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
EP0220234B1 (en) * 1985-04-08 1994-08-03 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
FI861626A (fi) * 1985-04-19 1986-10-20 Hoffmann La Roche Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids.
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0245362B1 (en) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetic peptides and use for diagnosis and vaccination for aids and arc
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
WO1988005051A1 (en) * 1986-12-30 1988-07-14 United States Of America, Represented By The Unite Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins

Also Published As

Publication number Publication date
PL155084B1 (en) 1991-10-31
CS275838B6 (en) 1992-03-18
IT1222518B (it) 1990-09-05
HUT44619A (en) 1988-03-28
PL267401A1 (en) 1988-07-21
NO934897L (no) 1993-12-29
AU616156B2 (en) 1991-10-24
NO934897D0 (no) 1993-12-29
NO873495L (no) 1988-02-22
DK433087D0 (da) 1987-08-19
IE60671B1 (en) 1994-08-10
SE506025C2 (sv) 1997-11-03
NO302176B1 (no) 1998-02-02
KR920008744B1 (ko) 1992-10-09
FI873553A0 (fi) 1987-08-17
CS8706136A2 (en) 1990-08-14
PT85567A (en) 1987-09-01
BE1000811A4 (fr) 1989-04-11
GB2196634A (en) 1988-05-05
AT398080B (de) 1994-09-26
IE872219L (en) 1988-02-20
NO873495D0 (no) 1987-08-19
CH675728A5 (ko) 1990-10-31
HU214439B (hu) 1998-03-30
AU7720187A (en) 1988-05-19
LU86972A1 (fr) 1988-03-02
GB2196634B (en) 1991-05-15
DK433087A (da) 1988-02-21
NL8701950A (nl) 1988-03-16
ES2010727A6 (es) 1989-12-01
NO300462B1 (no) 1997-06-02
PT85567B (pt) 1991-02-08
FR2603107B1 (fr) 1992-04-24
NZ221440A (en) 1991-11-26
YU152587A (sh) 1992-09-07
IT8721678A0 (it) 1987-08-19
IL83580A0 (en) 1988-01-31
OA08652A (fr) 1988-11-30
ATA208987A (de) 1994-01-15
SE8703225D0 (sv) 1987-08-19
ZW15487A1 (en) 1988-09-14
FI873553A (fi) 1988-02-21
SE8703225L (sv) 1988-02-21
IL83580A (en) 1992-11-15
DE3727703A1 (de) 1988-05-05
GB8719587D0 (en) 1987-09-23
FR2603107A1 (fr) 1988-02-26
GR871298B (en) 1988-01-12
JPS6485928A (en) 1989-03-30

Similar Documents

Publication Publication Date Title
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
TR24082A (tr) Herbisid triazolsulfanomidler bunlarin hazirlanma- sina mahsus usuller ve bunlari ihtiva eden bilesim ler
NO880268L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DE3783401D1 (de) Medizinische roehre und herstellungsverfahren.
DE3786173D1 (de) Menschlicher monoklonaler antikoerper und arzneimittel zur prophylaxe und behandlung von infektioesen krankheiten.
NO871759L (no) Fremgangsmaate for fremstilling av sucralfatpreparater.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.
ZA885334B (en) Monoclonal antibodies and methods for diagnosis for diagnosis of phytophthora infection
NO165395C (no) Fremgangsmaate for fremstilling av n-(sulfonylmetyl)formamider.
NO872633D0 (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
ZA882095B (en) Synthetic peptide antigens for the detection of hiv-1 infection
NO941347D0 (no) Fremgangsmåte for fremstilling av et humant monoklonalt antistoff
NO173340C (no) Humant protein C antistoff

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970830

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee